Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning [Seeking Alpha]
Elevance Health, Inc. (ELV)
Company Research
Source: Seeking Alpha
CEO Gail Boudreaux emphasized that "2026 is a year of execution and repositioning," with guidance reflecting "prudent, achievable assumptions, grounded in pricing discipline, operational rigor and targeted investments." She announced 2026 adjusted diluted earnings per share guidance Quick Insights Elevance Health expects 2026 adjusted diluted EPS of at least $25.50, with Medicaid and Medicare Advantage membership declines creating topline pressure but supporting margin improvement via deliberate portfolio actions and margin-focused strategies. Key risks include lagging Medicaid rates versus acuity/utilization, ongoing eligibility reverifications, Medicare Advantage funding not keeping pace with cost trends, and cost trend volatility, all of which could pressure profitability and membership. Elevance is adopting a conservative stance on M&A, prioritizing integration and selective share repurchases, has pulled forward some investment timing, and targets capital returns via disc
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (NYSE:ELV) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ELV&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen<MarketBeat
- How this generation of Olympic women erased the idea that motherhood is the end of a gold medal dream [CNN]CNN
- Cigna (CI) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]Yahoo! Finance
- Elevance Health (NYSE:ELV) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat
- Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.MarketBeat
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 2/6/26 - Form 10-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- ELV's page on the SEC website